vs

Side-by-side financial comparison of Dole plc (DOLE) and Labcorp (LH). Click either name above to swap in a different company.

Labcorp is the larger business by last-quarter revenue ($3.5B vs $2.3B, roughly 1.6× Dole plc). Labcorp runs the higher net margin — 7.9% vs 0.2%, a 7.6% gap on every dollar of revenue. On growth, Dole plc posted the faster year-over-year revenue change (10.5% vs 5.8%). Labcorp produced more free cash flow last quarter ($70.5M vs $66.5M). Over the past eight quarters, Labcorp's revenue compounded faster (4.8% CAGR vs 3.2%).

Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

DOLE vs LH — Head-to-Head

Bigger by revenue
LH
LH
1.6× larger
LH
$3.5B
$2.3B
DOLE
Growing faster (revenue YoY)
DOLE
DOLE
+4.7% gap
DOLE
10.5%
5.8%
LH
Higher net margin
LH
LH
7.6% more per $
LH
7.9%
0.2%
DOLE
More free cash flow
LH
LH
$4.0M more FCF
LH
$70.5M
$66.5M
DOLE
Faster 2-yr revenue CAGR
LH
LH
Annualised
LH
4.8%
3.2%
DOLE

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
DOLE
DOLE
LH
LH
Revenue
$2.3B
$3.5B
Net Profit
$5.1M
$277.8M
Gross Margin
6.8%
28.7%
Operating Margin
1.1%
10.8%
Net Margin
0.2%
7.9%
Revenue YoY
10.5%
5.8%
Net Profit YoY
-64.6%
30.5%
EPS (diluted)
$0.05
$3.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOLE
DOLE
LH
LH
Q1 26
$3.5B
Q4 25
$3.5B
Q3 25
$2.3B
$3.6B
Q2 25
$2.4B
$3.5B
Q1 25
$2.1B
$3.3B
Q4 24
$3.3B
Q3 24
$2.1B
$3.3B
Q2 24
$2.1B
$3.2B
Net Profit
DOLE
DOLE
LH
LH
Q1 26
$277.8M
Q4 25
$164.7M
Q3 25
$5.1M
$261.1M
Q2 25
$10.0M
$237.9M
Q1 25
$38.9M
$212.8M
Q4 24
$143.4M
Q3 24
$14.4M
$169.3M
Q2 24
$80.1M
$205.3M
Gross Margin
DOLE
DOLE
LH
LH
Q1 26
28.7%
Q4 25
28.2%
Q3 25
6.8%
28.8%
Q2 25
9.0%
29.7%
Q1 25
8.7%
28.3%
Q4 24
26.9%
Q3 24
8.0%
27.6%
Q2 24
9.4%
28.8%
Operating Margin
DOLE
DOLE
LH
LH
Q1 26
10.8%
Q4 25
7.6%
Q3 25
1.1%
11.1%
Q2 25
4.3%
11.2%
Q1 25
3.2%
9.7%
Q4 24
6.5%
Q3 24
2.3%
7.7%
Q2 24
4.0%
9.2%
Net Margin
DOLE
DOLE
LH
LH
Q1 26
7.9%
Q4 25
4.7%
Q3 25
0.2%
7.3%
Q2 25
0.4%
6.7%
Q1 25
1.9%
6.4%
Q4 24
4.3%
Q3 24
0.7%
5.2%
Q2 24
3.8%
6.4%
EPS (diluted)
DOLE
DOLE
LH
LH
Q1 26
$3.35
Q4 25
$1.98
Q3 25
$0.05
$3.12
Q2 25
$0.10
$2.84
Q1 25
$0.41
$2.52
Q4 24
$1.72
Q3 24
$0.15
$2.00
Q2 24
$0.84
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOLE
DOLE
LH
LH
Cash + ST InvestmentsLiquidity on hand
$321.0M
$981.1M
Total DebtLower is stronger
$5.8B
Stockholders' EquityBook value
$1.4B
$8.7B
Total Assets
$4.5B
$19.1B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOLE
DOLE
LH
LH
Q1 26
$981.1M
Q4 25
$532.3M
Q3 25
$321.0M
$598.1M
Q2 25
$323.1M
$647.3M
Q1 25
$261.0M
$369.4M
Q4 24
$1.5B
Q3 24
$266.4M
$1.5B
Q2 24
$225.8M
$265.1M
Total Debt
DOLE
DOLE
LH
LH
Q1 26
$5.8B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DOLE
DOLE
LH
LH
Q1 26
$8.7B
Q4 25
$8.6B
Q3 25
$1.4B
$8.7B
Q2 25
$1.4B
$8.5B
Q1 25
$1.3B
$8.3B
Q4 24
$8.1B
Q3 24
$1.4B
$8.2B
Q2 24
$1.4B
$8.0B
Total Assets
DOLE
DOLE
LH
LH
Q1 26
$19.1B
Q4 25
$18.4B
Q3 25
$4.5B
$18.3B
Q2 25
$4.7B
$18.1B
Q1 25
$4.5B
$17.6B
Q4 24
$18.4B
Q3 24
$4.5B
$18.6B
Q2 24
$4.4B
$16.7B
Debt / Equity
DOLE
DOLE
LH
LH
Q1 26
0.67×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOLE
DOLE
LH
LH
Operating Cash FlowLast quarter
$87.4M
$191.5M
Free Cash FlowOCF − Capex
$66.5M
$70.5M
FCF MarginFCF / Revenue
2.9%
2.0%
Capex IntensityCapex / Revenue
0.9%
3.4%
Cash ConversionOCF / Net Profit
17.12×
0.69×
TTM Free Cash FlowTrailing 4 quarters
$13.7M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOLE
DOLE
LH
LH
Q1 26
$191.5M
Q4 25
$614.2M
Q3 25
$87.4M
$387.2M
Q2 25
$18.3M
$620.6M
Q1 25
$-78.8M
$18.5M
Q4 24
$777.2M
Q3 24
$101.0M
$277.3M
Q2 24
$40.2M
$561.1M
Free Cash Flow
DOLE
DOLE
LH
LH
Q1 26
$70.5M
Q4 25
$490.3M
Q3 25
$66.5M
$280.5M
Q2 25
$-1.0M
$542.7M
Q1 25
$-131.6M
$-107.5M
Q4 24
$665.1M
Q3 24
$79.9M
$161.5M
Q2 24
$22.8M
$432.9M
FCF Margin
DOLE
DOLE
LH
LH
Q1 26
2.0%
Q4 25
13.9%
Q3 25
2.9%
7.9%
Q2 25
-0.0%
15.4%
Q1 25
-6.3%
-3.2%
Q4 24
20.0%
Q3 24
3.9%
4.9%
Q2 24
1.1%
13.4%
Capex Intensity
DOLE
DOLE
LH
LH
Q1 26
3.4%
Q4 25
3.5%
Q3 25
0.9%
3.0%
Q2 25
0.8%
2.2%
Q1 25
2.5%
3.8%
Q4 24
3.4%
Q3 24
1.0%
3.5%
Q2 24
0.8%
4.0%
Cash Conversion
DOLE
DOLE
LH
LH
Q1 26
0.69×
Q4 25
3.73×
Q3 25
17.12×
1.48×
Q2 25
1.84×
2.61×
Q1 25
-2.02×
0.09×
Q4 24
5.42×
Q3 24
7.01×
1.64×
Q2 24
0.50×
2.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOLE
DOLE

Segment breakdown not available.

LH
LH

Revenues$2.8B78%
Other$775.5M22%

Related Comparisons